SRPT
NASD Sarepta Therapeutics, Inc.$18.65 ↓ -0.15 (-0.80%) Trading Down from the previous close of $18.80
- YTD change
- -13.34%
- vs 20-day SMA
- -9.67%
- vs 200-day SMA
- -2.82%
Price ranges
Price & Performance
-1.68 (-8.20%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 89.7% away from all-time highs of $181.83
- SRPT is down 13% since the beginning of the year
- SRPT is down 1% over the past 12 months
- SRPT is down 11% over the past 1 month
- 25% of all SRPT investors are betting against SRPT
SRPT reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -0.1%.
- Previous minute
- +$0.00
- Last hour
- +$0.01
- Last 5 days
- -7.40%
- vs 8-day SMA
- -4.69%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
